May, 2009FDA Should Oversee Tobacco, Senate Panel Says
The Food and Drug Administration should be given authority to regulate the advertising and marketing of cigarettes and other tobacco products, a U.S. Senate panel said. If the Senate and the House formally adopt legislation that gains the approval of President Barack Obama, who is said to support the idea, the FDA would have new power over big tobacco, including the ability to restrict advertising of cigarettes to children, control nicotine content, and order changes to cigarette package warnings. Tobacco …
Continue →LexisNexis® Legal News Podcast for May 21, 2009
New York’s high court finds absent class members do not hold a presumptive right-of-access, and, the New Jersey Supreme Court says the state’s Property-Liability Insurance Guaranty Association does not have to reimburse a claimant. Hear these and other stories from LexisNexis® Mealey’s™ Discovery, Insurance Insolvency and Intellectual Property Reports. Copyright© 2009 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys.
Continue →Obama Issues Directive Limiting Federal Preemption of State Laws; Consumer Rights Attorneys Praise the Decision
President Barack Obama has just issued a directive limiting the use of federal preemption to override state laws which allow injured parties to sue the makers of defective medical devices and dangerous drugs for damages.
Continue →Researchers Find Link Between Irregular Heartbeat and Alzheimer’s Disease
Researchers in the United States say the heart rhythm disorder called atrial fibrillation may lead to development of the memory-robbing disorder Alzheimer’s disease. Scientists from the Intermountain Medical Center in Salt Lake City found in a study that older patients with atrial fibrillation were 44 percent more likely to develop dementia associated with Alzheimer’s disease. The news was even worse for younger patients — those under age 70 — with atrial fibrillation, who were 130 percent more likely to suffer …
Continue →Are We Losing the Fight Against Deadly Medical Errors?
A decade after U.S. healthcare authorities boldly declared war on deadly medical errors, little progress has been made in reducing the number of surgical mistakes, prescription errors, and other types of medical mishaps, a leading consumer group says.
Continue →Cancer Drug Rituxan Linked to Deadly Brain Infections
Rituxan, the brand name for the cancer-fighting drug rituximab, has been linked to dozens of cases of a swift and deadly brain infection, according to newly released research. A total of 57 cases of progressive multifocal leukoencephalitis (PML) in patients taking Rituxan for treatment of lymphoma have been reported from 1997 to 2008, according to a new study from the Northwestern University Feinberg School of Medicine RADAR project. Rituxan is most often given to treat patients with lymphoma, a cancer …
Continue →Freddie Mac Investors Expand Legal Claims of Fraudulent Lending
Investors suing residential mortgage lender Freddie Mac have added fuel to their fire accusing the company of lying about risky loans and reporting falsified financial returns.
Continue →Courts Best Suited To Oversee FDA, JAMA Commentary Says
The current issue of the Journal of the American Medical Association includes a commentary which states that the nation’s tort laws provide necessary oversight of the Food and Drug Administration while compensating people who are injured or killed by defective drugs and medical devices.
Continue →AstraZeneca Accused of Burying Seroquel Concerns
AstraZeneca, the British drug company behind the blockbuster antipsychotic Seroquel, prevented company scientists from going public with their concerns that the drug caused weight gain and other complications, according to lawyers suing the company. The company reportedly feared that releasing the concerns about adverse effects from Seroquel might hurt sales of the drug, said plaintiff’s attorneys citing a string of internal emails just released as part of thousands of lawsuits against AstraZeneca. About 15,000 lawsuits have been filed on behalf …
Continue →LexisNexis® Legal News Podcast for May 20, 2009
President Obama proposes federal fuel efficiency standards that would regulate and cut greenhouse gas emissions, and, the California Supreme Court says Proposition 64 does not require class-wide reliance. Hear these and other stories from LexisNexis® Mealey’s™ Pollution Liability, California Section 17200, Discovery and Intellectual Property Reports. Copyright© 2009 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys.
Continue →Recent Related Features
All Stories




facebook
rss
twitter